Clinical Trials Arena January 18, 2023
Asia-Pacific emerges as one of the most promising and resilient markets for clinical trials.
The global clinical trials landscape has seen continued growth between 2017 and 2022. While all regions have faced significant disruption, including the effects of the COVID-19 pandemic and macroeconomic factors, the Asia-Pacific (APAC) region has emerged as the site of sustainable growth and enormous future opportunity. Of almost 27,000 clinical trials initiated in 2021, nearly half of them had locations in APAC.
A new report by APAC clinical research organisation Novotech and GlobalData reveals how metrics including trial numbers, growth and density cluster in APAC to make it one of the most promising geographies for future clinical research. Download the report below to deep dive...
Today's Sponsors
Today's Sponsor